Zip Arthroplasty Patient Satisfaction Evaluation

Knee Arthroplasty Clinical Trial

— ZAPS  

Official title:

Zip Arthroplasty Patient Satisfaction Evaluation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03178266
• Other study ID #: 011
• Status: Completed
• Start date: December 1, 2017
• Est. completion date: May 1, 2018

Study information

• Verified date: May 2019
• Source: ZipLine Medical Inc.
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is a prospective, randomized, single center, study to evaluate Zip Closure Device in subjects undergoing knee arthroplasty. Patients identified as candidates for knee arthroplasty and meet the study selection criteria will be approached and considered for the study. Knee Arthroplasty of 40 subjects will be enrolled where 20 subjects will receive ZipLine and 20 subjects will receive Staples.

Description:

Sutures and metal staples are considered standard of care methods for surgical skin closure. The Zip® Surgical Skin Closure device from ZipLine Medical, Inc. (Campbell, CA USA) is a more recent method of skin closure that utilizes skin adhesive and adjustable ratcheting straps to achieve and maintain tension necessary for wound closure and healing. The Zip device was designated Class I, 510(k) Exempt by the US FDA in 2010, and the CE Mark was affixed in 2014.

Limited patient-reported satisfaction data exists for the Zip device as compared to staples and sutures, so this study will attempt to address this need.

The purpose of the study is to evaluate patient satisfaction of closure method used after knee joint arthroplasty. Metal staples and the Zip® Surgical Skin Closure device are approved methods in regular use. Selection of method is generally based on physician preference. This study is to determine what, if any, differences exist in patient satisfaction amongst the two methods

Recruitment information / eligibility

• Status: Completed
• Enrollment: 41
• Est. completion date: May 1, 2018
• Est. primary completion date: May 1, 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 80 Years

Eligibility

Inclusion Criteria:

1. Patients undergoing primary elective knee arthroplasty.

2. Willing and able to provide informed consent and/or obtain legal guardian authorization

3. Willing and able to comply with the subject-specific requirements outlined in the study protocol

Exclusion Criteria:

1. Patients that do not meet the conditions listed in the wound closure device warnings, precautions, and contraindications (Appendix A)

2. Patients with comorbidities or conditions that the investigator deems to be ineligible for the study

3. Patients without the capacity to give informed consent (e.g., dementia)

Related Conditions & MeSH terms

• Knee Arthroplasty

Intervention

Device:
• Knee Arthroplasty
Standard Knee Arthroplasty will be performed on study subjects. The closure method will be studied at 3 weeks and 6 weeks and patients will be asked about satisfaction with the closure method assigned.

Locations

Country	Name	City	State
United States	Montgomery Orthopaedics Associates	Norristown	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
ZipLine Medical Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient and Observer Scar Assessment Scale (POSAS)	The subject and investigator will rate commonly described scar characteristics from a patient and observers perspective Subject and Physician will rate overall opinion of scar to normal skin where 1-Normal to 10-Very Different	6 weeks post knee arthroplasty
Secondary	Patient Satisfaction	Subject Experience and Satisfaction results at 6 weeks post procedure. Subjects are asked of satisfaction with scar appearance on a scale of 1-minimal scar to 5-significant scar	6 weeks post knee arthroplasty